ShareValue scores for RPID: Valuation 44, Quality 48, Growth 60, Health 36.

Rapid Micro Biosystems Inc logo

RPID
NASDAQ

Rapid Micro Biosystems Inc

$2.08(-1.42%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 16%
Valuation
44
Fair Value
Price vs Value
Quality
48
Moderate
Business Strength
Growth
60
Moderate
Revenue & Earnings
Health
36
Stressed
Financial Stability
Momentum
33
Bearish
Price Trend

Company Details

About

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026